Therefore, the results suggested that CD27-AS1 could regulate AML cell progression through a miR-224-5p/PBX3/MAPK signaling pathway, which may provide new insights for noncoding RNA-related therapeutic intervention of AML treatment. Here, CD27 is linked to acute myeloid leukemia.